Publications by the researcher in collaboration with Carlos Diéguez González (314)

2022

  1. Kappa-Opioid Receptor Blockade Ameliorates Obesity Caused by Estrogen Withdrawal via Promotion of Energy Expenditure through mTOR Pathway

    International Journal of Molecular Sciences, Vol. 23, Núm. 6

  2. LEAP-2 Counteracts Ghrelin-Induced Food Intake in a NutrientGrowth Hormone and Age Independent Manner

    Cells, Vol. 11, Núm. 3

  3. Prolonged breastfeeding protects from obesity by hypothalamic action of hepatic FGF21

    Nature Metabolism, Vol. 4, Núm. 7, pp. 901-917

2021

  1. Antagonists of growth hormone-releasing hormone inhibit the growth of pituitary adenoma cells by hampering oncogenic pathways and promoting apoptotic signaling

    Cancers, Vol. 13, Núm. 16

  2. Multifaceted actions of melanin-concentrating hormone on mammalian energy homeostasis

    Nature Reviews Endocrinology, Vol. 17, Núm. 12, pp. 745-755

  3. RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas

    Oncogene, Vol. 40, Núm. 45, pp. 6354-6368

  4. Sirt3 in POMC neurons controls energy balance in a sex- and diet-dependent manner

    Redox Biology, Vol. 41

2020

  1. Oral Pharmacological Activation of Hypothalamic Guanylate Cyclase 2C Receptor Stimulates Brown Fat Thermogenesis to Reduce Body Weight

    Neuroendocrinology, Vol. 110, Núm. 11-12, pp. 1042-1053

  2. Vav2 catalysis-dependent pathways contribute to skeletal muscle growth and metabolic homeostasis

    Nature Communications, Vol. 11, Núm. 1

2019

  1. ANGPTL-4 is associated with obesity and lipid profile in children and adolescents

    Nutrients, Vol. 11, Núm. 6

  2. Exciting advances in GPCR-based drugs discovery for treating metabolic disease and future perspectives

    Expert Opinion on Drug Discovery, Vol. 14, Núm. 5, pp. 421-431

  3. Ghrelin and food reward

    Neuropharmacology, Vol. 148, pp. 131-138

  4. Glucagon control on food intake and energy balance

    International Journal of Molecular Sciences, Vol. 20, Núm. 16

  5. MCH regulates SIRT1/FoxO1 and reduces POMC neuronal activity to induce hyperphagia, adiposity, and glucose intolerance

    Diabetes, Vol. 68, Núm. 12, pp. 2210-2222

  6. Uroguanylin improves leptin responsiveness in diet-induced obese mice

    Nutrients, Vol. 11, Núm. 4

  7. Vagal afferents contribute to sympathoexcitation-driven metabolic dysfunctions

    Journal of Endocrinology, Vol. 240, Núm. 3, pp. 483-496

2018

  1. Circulating Pro-Uroguanylin Levels In Children And Their Relation To Obesity, Sex And Puberty

    Scientific Reports, Vol. 8, Núm. 1

  2. Corrigendum: Validation of the Spanish version of the yale food addiction scale 2.0 (YFAS 2.0) and clinical correlates in a sample of eating disorder, gambling disorder and healthy control participants [Front. Psychiatry, 9, (2018), (208)] doi: 10.3389/fpsyt.2018.00208

    Frontiers in Psychiatry

  3. Ghrelin and LEAP-2: Rivals in Energy Metabolism

    Trends in Pharmacological Sciences, Vol. 39, Núm. 8, pp. 685-694

  4. Plasma ANGPTL-4 is Associated with Obesity and Glucose Tolerance: Cross-Sectional and Longitudinal Findings

    Molecular Nutrition and Food Research, Vol. 62, Núm. 10